Rubius Therapeutics Inc (NASDAQ:RUBY)

0.2675
BATS BZX Real-Time Price
As of 11:05am ET
 -0.0715 / -21.09%
Today’s Change
0.14
Today|||52-Week Range
6.54
+52.86%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +1,021.50% increase from the last price of 0.27.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Rubius Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.42
Sales
$0.00
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.59%
 
 
 
 
 
 
Growthannually 19.28%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.